LSUHSC research finds inflammation linked to obesity in adults may be protective in young children

December 04, 2013

New Orleans, LA - The first study of its kind, led by Melinda Sothern, PhD, CEP, Professor and Director of Behavioral and Community Health Sciences at LSU Health Sciences Center New Orleans School of Public Health, reveals that the same pro-inflammatory proteins linked to obesity and the metabolic syndrome in adults appear to protect children prior to puberty. The findings are published online in the International Journal of Obesity in the Accepted Article Preview.

"With obesity now at epidemic proportions along with a rise in the number of those with the metabolic syndrome, it is crucial that we better understand how and when obesity and insulin resistance develop," notes Dr. Sothern. "In adults, obesity is linked to inflammation. In young children, however, the relationship between inflammation and body fat is unclear."

The research team studied a group of healthy obese and non-obese African-American and Caucasian children, 7-9 years old who had not yet entered puberty. They looked at circulating pro and anti-inflammatory molecules, abdominal fat, BMI, insulin resistance, fatty tissue beneath the skin, fat in the liver, and total fat in order to better understand the role inflammation plays in the development of obesity and insulin resistance.

"We found that relationships between pro-inflammatory and metabolic markers commonly observed in adults were reversed in healthy, African-American and Caucasian obese and non-obese children who had not yet entered puberty," says Dr. Sothern.

Although the pro-inflammatory proteins associated with obesity may cause damage to the heart, blood vessels and insulin function in adults, in this group of young children, they appear to be helpful. The researchers pose a number of explanations for their findings. Normal growth may temporarily increase inflammation, and the presence of the inflammatory biomarkers may actually preserve glucose stability. It may also be that the presence of an existing inflammatory environment is crucial for defending the body against infection, allergies, and other insults prior to puberty. Also, both metabolism and inflammation are affected by physical activity, which is higher in young, healthy children as opposed to adults.

"The chronic nature of this inflammatory environment, while beneficial during developmental stages, may, however, lead to undesirable immune responses associated with disease later in life," says lead author Jovanny Zabaleta, PhD, Assistant Professor-Research in the Department of Pediatrics and the Stanley S. Scott Cancer Center at LSU Health Sciences Center New Orleans.

The World Health Organization (WHO) projects there will be more than 2 billion overweight and more than 700 million obese adults by 2015. Obesity affects all ethnicities, but in the US, minority populations and those from disadvantaged backgrounds are most affected. Similar trends are found in young children prior to puberty whose obesity continues into adolescence. Remarkably, more than half of overweight adolescents carry this condition into adulthood.

"Further studies are needed to determine how these inverse relationships modify chronic disease risk later in life as these unexpected findings provide compelling evidence to inform clinical practice, especially in severely obese pre-pubertal children with related inflammatory conditions such as asthma, fatty liver disease, and insulin resistance," concludes Dr. Sothern.
-end-
The LSUHSC research team also included Cruz Velasco-Gonzalez, PhD, John Estrada, MD, Nicole Pelligrino, MPH, Maura C. Mohler, MPH, Hamid Boulares, PhD, Kyle Happel, MD, William Cefalu, MD, Richard Scribner, MD, MPH, and Tung-Sung Tseng, PhD, from the LSUHSC schools of public health and medicine. Eric Ravussin, PhD, from LSU's Pennington Biomedical Research Center, Yolanda Powell-Young, PhD, from Dillard University, Brian Bennett, MPH, from the Louisiana Department of Public Health, and Enette Larsen-Meyer, PhD, from the University of Wyoming, also participated.

The research was supported by grants from the National Institutes of Health.

LSU Health Sciences Center New Orleans educates Louisiana's health care professionals. The state's academic health leader, LSUHSC comprises a School of Medicine, the state's only School of Dentistry, Louisiana's only public School of Public Health, and Schools of Allied Health Professions, Nursing, and Graduate Studies. Louisiana's flagship academic health center, LSUHSC faculty take care of patients in public and private hospitals and clinics throughout the region. In the vanguard of biosciences research in a number of areas in a worldwide arena, the LSUHSC research enterprise generates jobs and enormous economic impact. LSUHSC faculty have made lifesaving discoveries and continue to work to prevent, advance treatment, or cure disease. To learn more, visit http://www.lsuhsc.edu and http://www.twitter.com/LSUHSCHealth

Louisiana State University Health Sciences Center

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.